Literature DB >> 19394254

QSAR analysis for quinoxaline-2-carboxylate 1,4-di-N-oxides as anti-mycobacterial agents.

Esther Vicente1, Pablo R Duchowicz, Eduardo A Castro, Antonio Monge.   

Abstract

In a continuing effort of our research group to identify new active compounds against Mycobacterium tuberculosis, we resort to the quantitative structure-activity relationships (QSARs) theory. For this purpose, we employ certain parameters of potency, cytotoxicity and selectivity as given by the Tuberculosis Antimicrobial Acquisition & Coordinating Facility (TAACF) program. The molecular structure of 43 quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives is appropriately represented by 1497 DRAGON type of theoretical descriptors, and the best linear regression models established in this work are demonstrated to result predictive. The application of the QSAR equations developed now serves as a rational guide for the proposal of new candidate structures that still do not have experimentally assigned biological data.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394254     DOI: 10.1016/j.jmgm.2009.03.004

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  5 in total

1.  A novel benzodioxole-containing inhibitor of Toxoplasma gondii growth alters the parasite cell cycle.

Authors:  Edwin Kamau; Tracy Meehan; Mark D Lavine; Gustavo Arrizabalaga; Gabriela Mustata Wilson; Jon Boyle
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

2.  Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.

Authors:  Mohamed Alswah; Ashraf H Bayoumi; Kamal Elgamal; Ahmed Elmorsy; Saleh Ihmaid; Hany E A Ahmed
Journal:  Molecules       Date:  2017-12-27       Impact factor: 4.411

3.  Synthesis of novel, DNA binding heterocyclic dehydroabietylamine derivatives as potential antiproliferative and apoptosis-inducing agents.

Authors:  Fengyi Zhao; Xu Sun; Wen Lu; Li Xu; Jiuzhou Shi; Shilong Yang; Mengyi Zhou; Fan Su; Feng Lin; Fuliang Cao
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

4.  In vitro antimicrobial activities of animal-used quinoxaline 1,4-di-N-oxides against mycobacteria, mycoplasma and fungi.

Authors:  Yan Zhao; Guyue Cheng; Haihong Hao; Yuanhu Pan; Zhenli Liu; Menghong Dai; Zonghui Yuan
Journal:  BMC Vet Res       Date:  2016-09-06       Impact factor: 2.741

5.  Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.

Authors:  Saioa Ancizu; Elsa Moreno; Enrique Torres; Asunción Burguete; Silvia Pérez-Silanes; Diego Benítez; Raquel Villar; Beatriz Solano; Adoración Marín; Ignacio Aldana; Hugo Cerecetto; Mercedes González; Antonio Monge
Journal:  Molecules       Date:  2009-06-22       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.